Recently, the presence of both epithelial and quasi-mesenchymal subtypes of cancer cells was identified in PDAC42; selection strategies targeting EpCAM only may not fully recapitulate the primary/metastatic tumor and provide insufficient information for patients with a non-epithelial PDAC subtype. This evidence concerns the gene EPCAM and cancer.